CARECLOUD INC - CCLD 8 3/4 PERP (CCLDO) Stock Fundamental Analysis
NASDAQ:CCLDO - US14167R3084
21.23 USD
-0.5 (-2.3%)
CCLDO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. While CCLDO has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, CCLDO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CCLDO had negative earnings in the past year.
In the past year CCLDO had a positive cash flow from operations.
CCLDO had negative earnings in each of the past 5 years.
Of the past 5 years CCLDO 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 0.02%, CCLDO is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.02%, CCLDO is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 16.12%, CCLDO belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROIC | 16.12% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of CCLDO (0.01%) is better than 80.00% of its industry peers.
With an excellent Operating Margin value of 10.77%, CCLDO belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of CCLDO has grown nicely.
CCLDO's Gross Margin of 46.00% is on the low side compared to the rest of the industry. CCLDO is outperformed by 65.71% of its industry peers.
CCLDO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCLDO is creating some value.
The number of shares outstanding for CCLDO has been increased compared to 1 year ago.
CCLDO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCLDO has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 29.22 indicates that CCLDO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 29.22, CCLDO belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
The Debt to FCF ratio of CCLDO is 0.02, which is an excellent value as it means it would take CCLDO, only 0.02 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.02, CCLDO belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
CCLDO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CCLDO's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. CCLDO outperforms 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Altman-Z | 29.22 |
ROIC/WACC1.64
WACC9.8%
2.3 Liquidity
CCLDO has a Current Ratio of 1.91. This is a normal value and indicates that CCLDO is financially healthy and should not expect problems in meeting its short term obligations.
CCLDO's Current ratio of 1.91 is in line compared to the rest of the industry. CCLDO outperforms 42.86% of its industry peers.
A Quick Ratio of 1.88 indicates that CCLDO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.88, CCLDO is in line with its industry, outperforming 42.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 |
3. Growth
3.1 Past
CCLDO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 95.70%, which is quite impressive.
The Revenue has been growing slightly by 0.04% in the past year.
CCLDO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.47% yearly.
EPS 1Y (TTM)95.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.54%
3.2 Future
CCLDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.19% yearly.
The Revenue is expected to grow by 3.92% on average over the next years.
EPS Next Y152.7%
EPS Next 2Y63.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.43%
Revenue Next 2Y3.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CCLDO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CCLDO is valuated quite expensively with a Price/Forward Earnings ratio of 160.11.
CCLDO's Price/Forward Earnings ratio is in line with the industry average.
CCLDO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 160.11 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CCLDO is valued a bit cheaper than 65.71% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCLDO is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.59 | ||
| EV/EBITDA | 35.19 |
4.3 Compensation for Growth
CCLDO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CCLDO's earnings are expected to grow with 63.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y63.19%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.67%, CCLDO is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.82, CCLDO pays a better dividend. On top of this CCLDO pays more dividend than 97.14% of the companies listed in the same industry.
CCLDO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.67% |
5.2 History
The dividend of CCLDO is nicely growing with an annual growth rate of 21.20%!
CCLDO has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)21.2%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The dividend of CCLDO is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y63.19%
EPS Next 3YN/A
CARECLOUD INC - CCLD 8 3/4 PERP
NASDAQ:CCLDO (9/9/2025, 8:00:02 PM)
21.23
-0.5 (-2.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners16.98%
Inst Owner ChangeN/A
Ins Owners14.3%
Ins Owner ChangeN/A
Market Cap898.45M
Analysts80
Price Target29.49 (38.91%)
Short Float %0%
Short Ratio0.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.67% |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.82%
Min EPS beat(2)21.57%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)72.28%
Min EPS beat(4)21.57%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)-0.12%
EPS beat(12)8
Avg EPS beat(12)-1.47%
EPS beat(16)12
Avg EPS beat(16)11.57%
Revenue beat(2)1
Avg Revenue beat(2)2.17%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)5.6%
Revenue beat(4)1
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)5.6%
Revenue beat(8)1
Avg Revenue beat(8)-2.29%
Revenue beat(12)1
Avg Revenue beat(12)-3.19%
Revenue beat(16)3
Avg Revenue beat(16)-2.21%
PT rev (1m)-22.91%
PT rev (3m)-34.21%
EPS NQ rev (1m)-21.43%
EPS NQ rev (3m)197.79%
EPS NY rev (1m)3.33%
EPS NY rev (3m)3.33%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)-0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 160.11 | ||
| P/S | 8.04 | ||
| P/FCF | 51.59 | ||
| P/OCF | 36.21 | ||
| P/B | 16.02 | ||
| P/tB | 42.04 | ||
| EV/EBITDA | 35.19 |
EPS(TTM)-0.04
EYN/A
EPS(NY)0.13
Fwd EY0.62%
FCF(TTM)0.41
FCFY1.94%
OCF(TTM)0.59
OCFY2.76%
SpS2.64
BVpS1.33
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.02% | ||
| ROE | 0.02% | ||
| ROCE | 20.4% | ||
| ROIC | 16.12% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 39.14% | ||
| OM | 10.77% | ||
| PM (TTM) | 0.01% | ||
| GM | 46% | ||
| FCFM | 15.58% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y52.71%
ROICexcg growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score7
Asset Turnover1.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.02 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 54.79% | ||
| Cap/Sales | 6.62% | ||
| Interest Coverage | 63.03 | ||
| Cash Conversion | 97.14% | ||
| Profit Quality | 124386% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.88 | ||
| Altman-Z | 29.22 |
F-Score7
WACC9.8%
ROIC/WACC1.64
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.57%
EPS Next Y152.7%
EPS Next 2Y63.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.04%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%-2.54%
Revenue Next Year0.43%
Revenue Next 2Y3.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15735.1%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year208.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.11%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y21.45%
OCF growth 3Y15.69%
OCF growth 5Y22.06%